A Randomized Controlled Trial of Oxytocin Nasal Spray for Alcohol Dependence

Phase 2

Recruiting

• Conditions: alcohol dependence; Mental Health - Addiction

• Registration Number: ACTRN12617001626358
• Lead Sponsor: The University of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-12-13
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

•Aged between 18 and 65 years of age
•Meet the International Classification of Diseases, 10th Revision (ICD10), criteria for alcohol dependence
•Fluency in English
•Ability to give informed consent

Exclusion Criteria

•Women lactating, pregnant or childbearing potential who are not willing to avoid pregnancy during the study
•Meet criteria for severe acute psychiatric disorders including psychosis or moderate/high risk for self-harm (suicidality)
•Meet International Statistical Classification of Diseases and Related Health Problems (ICD-10) criteria for another substance dependence (other than nicotine, due to high comorbidity between these disorders
•Currently participating in another substance use treatment
•People with pending legal charges and potential incarceration
•IQ below 75 (assessed using the Weschler Test of Adult Reading (WTAR)
•Those who have severely compromised cardiac, hepatic or renal function (evidenced at medical examination)
•Use of benzodiazepines

Study & Design

• Study Type: Interventional
• Study Design: Not specified